Lataa...
Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations
Despite the established efficacy of sorafenib in advanced hepatocellular carcinoma (HCC), a significant number of sorafenib-treated patients experience disease progression. Current guidelines recommend either best supportive care or clinical trial enrollment for this population. As such, there remai...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3808569/ https://ncbi.nlm.nih.gov/pubmed/24179481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X13498540 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|